Ondansetron HCL 8 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FNAVL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,217
Award facts
- Contract value 100% obligated
- $29,216.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $29,216.64 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract was executed on September 18, 2025, with an ultimate completion date of September 19, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains a comprehensive portfolio of pharmaceutical products available through its DLA contract vehicle, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. No set-aside designation was applied to this award, indicating it was awarded through open competition. This delivery order for Ondansetron, an antiemetic medication commonly used in medical settings, exemplifies the routine pharmaceutical supply operations that AmerisourceBergen conducts under its prime contract with the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FNAVL?
SPE2DB25FNAVL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FNAVL worth?
The government has obligated $29,217 on SPE2DB25FNAVL.
Is contract SPE2DB25FNAVL an order under another contract?
Yes. SPE2DB25FNAVL is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FNAVL competed?
The extent of competition for SPE2DB25FNAVL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award